A study to investigate the safety, tolerability, and efficacy of AZD0120 in adults with Refractory SLE

Trial Identifier:	D8313C00001
Sponsor:	AstraZeneca
Start Date:	April 2025
Primary Completion Date:	May 2029
Study Completion Date:	May 2029
Condition:	Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, New York	Syracuse, New York, US, 13202-2240
US, NY	New York, NY, US, 10032
US, WA	Seattle, WA, US, 98104

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.